1. Home
  2. ATRO vs AUPH Comparison

ATRO vs AUPH Comparison

Compare ATRO & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astronics Corporation

ATRO

Astronics Corporation

N/A

Current Price

$59.45

Market Cap

2.6B

Sector

Industrials

ML Signal

N/A

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$16.67

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATRO
AUPH
Founded
1968
1993
Country
United States
Canada
Employees
2700
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
ATRO
AUPH
Price
$59.45
$16.67
Analyst Decision
Buy
Buy
Analyst Count
5
7
Target Price
★ $98.00
$18.00
AVG Volume (30 Days)
457.5K
★ 739.2K
Earning Date
11-10-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 276.09
N/A
EPS
★ 1.31
0.76
Revenue
★ $862,128,000.00
$283,055,000.00
Revenue This Year
$19.84
$16.68
Revenue Next Year
$9.74
$17.60
P/E Ratio
$47.76
★ $32.44
Revenue Growth
★ 8.39
N/A
52 Week Low
$41.50
$12.79
52 Week High
$99.89
$19.25

Technical Indicators

Market Signals
Indicator
ATRO
AUPH
Relative Strength Index (RSI) 38.11 50.56
Support Level $56.20 $15.27
Resistance Level $78.00 $17.16
Average True Range (ATR) 2.76 0.45
MACD 0.24 0.03
Stochastic Oscillator 34.35 41.54

Price Performance

Historical Comparison
ATRO
AUPH

About ATRO Astronics Corporation

Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: